Erasca's private placement financing is viewed positively, e...
Erasca's private placement financing is viewed positively, extending its cash runway into H2 2026 and enabling continued R&D efforts. The company's focus on RAS/MAPK pathway-driven cancers and its promising pipeline have drawn investor interest.
Press Release: Erasca Announces $45 Million Oversubscribed Private Placement Financing
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment